v3.25.3
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenue:        
Premium revenue $ 10,841 $ 9,694 $ 32,337 $ 28,644
Premium tax revenue 506 508 1,325 1,103
Investment income 108 118 322 341
Other revenue 22 20 67 63
Total revenue 11,477 10,340 34,051 30,151
Operating expenses:        
Medical care costs 10,044 8,643 29,352 25,425
General and administrative expenses 729 676 2,214 2,078
Premium tax expenses 506 508 1,325 1,103
Depreciation and amortization 45 47 151 138
Other 16 (1) 66 80
Total operating expenses 11,340 9,873 33,108 28,824
Operating income 137 467 943 1,327
Interest expense 49 29 140 84
Income before income tax expense 88 438 803 1,243
Income tax expense 9 112 171 315
Net income $ 79 $ 326 $ 632 $ 928
Net income per share - Basic (in dollars per share) $ 1.51 $ 5.67 $ 11.81 $ 16.05
Net income per share - Diluted (in dollars per share) $ 1.51 $ 5.65 $ 11.79 $ 15.97